Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1MERCK & CIE KMG Schaffhausen CH

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

Looking for Certificates of Suitability (CEPs) for R1-CEP 2004-254 - Rev 01 of Merck & Cie Kmg Schaffhausen Ch

Looking for Certificates of Suitability (CEPs) for R1-CEP 2004-254 - Rev 01 of Merck & Cie Kmg Schaffhausen Ch 1

20

Merck & Cie Kmg Schaffhausen Ch, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA.

One of their significant offerings is Mesalazine, Micronised, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2004-254 - Rev 01

This Chemical Type CEP, issued on January 31, 2013, remains in force until September 29, 2015, ensuring its reliability within the pharmaceutical industry.

Substance Number 1699 associated with this CEP further emphasizes